Xcout Intel
Terrestrial Bio, Inc.
Terrestrial Bio, Inc. develops the Tacterra microarray patch platform to deliver next-generation therapies, such as GLP-1, through the skin using dissolvable biomaterial tips. The technology eliminates the need for needles and refrigeration, enabling patients to self-administer treatments pain-free at home or on the go.
Subscribe to see Terrestrial Bio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Terrestrial Bio, Inc. at a glance
Terrestrial Bio, Inc. is a biotech company. Its most recent funding round, Series C, raised $57.3M in March 2026. Xcout tracks 16 named people at Terrestrial Bio, Inc., including Rachel Sha (Chief Executive Officer, Board Member). Xcout recorded 31 job postings from Terrestrial Bio, Inc. in the last 90 days, naming tools such as NetSuite.
Terrestrial Bio, Inc. leadership
- Rachel ShaChief Executive Officer, Board Member
- Lynda TusseyChief Development Officer
- Kathryn KosudaCo-Founder, Chief Scientific Officer, Board Member
- Livio ValentiCo-founder, Senior VP of Operations and Public and Private Partnerships
- John SpiridigliozziVP of Product Development
- Jonathan KlugeVP of Research and Development
10 more named people on record for Terrestrial Bio, Inc., with roles, board committees and tenure — see the full roster →
Terrestrial Bio, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $57.3M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Terrestrial Bio, Inc.
Xcout recorded 31 job postings from Terrestrial Bio, Inc. in the last 90 days, from a hiring record Xcout has kept since August 2026.
Tools named in Terrestrial Bio, Inc.'s job postings
The weekly hiring trend, the roles and locations behind it — see Terrestrial Bio, Inc.'s hiring signals →
Investors
Tech stack
Terrestrial Bio, Inc. competitors
A few of Terrestrial Bio, Inc.'s closest competitors — see the full list of competitors and alternatives →
Biora Therapeutics is a U.S. biotechnology company developing ingestible, device-based platforms for delivering biologic medicines to targeted areas of the gastrointestinal tract and into systemic circulation. Its technologies are intended for use by pharmaceutical and biotechnology companies developing oral or targeted biologic therapies.
Panther Life Sciences is a privately held biotechnology company founded in 2023 and headquartered in New York, NY. The company licenses and develops new treatments utilizing dissolvable microarray patch (MAP) technology to deliver shelf-stable medicine through the skin.
Amorphex Therapeutics Holdings Inc. develops ocular drug delivery technologies, specifically a patented device called TODDD designed to continuously deliver medication to the eye for multiple months. The device is worn under the eyelid to replace daily eye drop therapy, serving patients with ophthalmic conditions such as glaucoma, retinal diseases, and myopia progression.
Theradaptive, Inc. is a clinical-stage biotechnology company headquartered in Frederick, Maryland, that engineers proteins to bind materials for targeted tissue therapeutics, tissue regeneration, and implantable delivery devices.
Micron Biomedical, Inc. is a clinical-stage biopharmaceutical and life science company committed to expanding global access to therapeutics and vaccines formulated into proprietary array-based delivery technologies.
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.
Get Terrestrial Bio, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Terrestrial Bio, Inc. in Xcout Intel
- 16 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access